Koers Advanced Oncotherapy plc
Aandelen
AVO
GB00BD6SX109
Geavanceerde medische apparatuur & technologie
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,75 GBX | -9,09% | -.--% | -.--% |
03/05 | Financieringsgesprekken Advanced Oncotherapy gaan door, fondsen vertraagd | AN |
02/04 | Sareum verhoogt bod op detailhandel; SThree haalt voormalig ITV-directeur binnen | AN |
Omzet 2020 | - | Omzet 2021 | - | Marktkapitalisatie | 172 mln. 158 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2020 | -25 mln. -23,05 mln. | Nettowinst (verlies) 2021 | -29 mln. -26,74 mln. | EV/omzet 2020 | - |
Nettoschuld 2020 | 48,32 mln. 44,55 mln. | Nettoschuld 2021 | 49,09 mln. 45,27 mln. | EV/omzet 2021 | - |
K/w-verhouding 2020 |
-4,11
x | K/w-verhouding 2021 |
-4,93
x | Werknemers | 174 |
Dividendrendement 2020 * |
-
| Dividendrendement 2021 |
-
| Vrij verhandelbaar | 52,47% |
1 dag | -9,09% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 49 | 27-08-14 | |
Director of Finance/CFO | - | 01-10-16 | |
Michael Sinclair
CHM | Chairman | 82 | 16-06-06 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Lori Cross
BRD | Director/Board Member | 64 | 29-09-20 |
Michael Sinclair
CHM | Chairman | 82 | 16-06-06 |
Hans von Celsing
BRD | Director/Board Member | 74 | 26-01-17 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-.--% | 12,08 mln. | |
+7,01% | 217 mld. | |
+11,01% | 190 mld. | |
+19,20% | 143 mld. | |
+30,72% | 111 mld. | |
+1,48% | 64,59 mld. | |
+13,95% | 52,36 mld. | |
-0,16% | 48,45 mld. | |
-6,20% | 38,03 mld. | |
+0,88% | 35,61 mld. |